Redemplo® (plozasiran): A Treatment to Lower Triglycerides for Adults With Familial Chylomicronemia Syndrome (FCS)Industry Webcast Sponsored by Arrowhead Pharmaceuticals; Not for CME/CE Credit

Join our Expert Theater for an educational overview of Redemplo^® (plozasiran), a treatment to lower triglycerides as an adjunct to diet in adults with Familial Chylomicronemia Syndrome (FCS), a rare and often underdiagnosed condition.

Watch

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 7/8/2026

Expiration Date: 7/8/2026

Topics

Faculty

Archna Bajaj, MD

Faculty

Archna Bajaj, MD

Learn More

Industry Sponsor

Arrowhead Pharmaceuticals

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.